Rejoyn

Rejoyn (Otsuka and Click Therapeutics) is the first FDA-cleared prescription digital therapeutic for major depressive disorder, a six-week smartphone program combining cognitive-emotional training exercises with brief CBT lessons, prescribed as an adjunct to clinician-managed care for adults 22+ on antidepressants. As an FDA-authorized medical device (not a wellness app), it gives clinicians a prescribable, evidence-based between-session tool. Confirm data/privacy terms for your patients.